FDA Week - 10/06/2017

Gottlieb Calls For Changes To Senate-Passed Right To Try Bill

October 05, 2017
FDA Commissioner Scott Gottlieb urged lawmakers Tuesday (Oct. 3) to revamp the Senate-passed Right to Try legislation now pending in the lower chamber by narrowing the patient population covered, further restricting promotion and commercialization of the experimental drugs, ensuring FDA's authority to take certain enforcement actions and protecting FDA from federal tort liability. Gottlieb outlined FDA's concerns at a House Energy & Commerce subcommittee hearing held two months after the Senate passed an amended version of Sen. Ron Johnson's (R-WI)...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, news from FDA and much more.